Disclosures for "A Phase 4, Open-label Study Evaluating the Safety and Tolerability of Once Daily Rimegepant for Episodic Migraine Prevention"
-
Jeremias Antinew has received personal compensation for serving as an employee of Pfizer Inc.
-
Robert Fountaine has received personal compensation for serving as an employee of Pfizer, Inc.. Robert Fountaine has stock in Pfizer, Inc. Robert Fountaine has stock in Viatris, Inc.
-
Dr. Loprinzo has received personal compensation for serving as an employee of Pfizer, Inc. Dr. Loprinzo has stock in Pfizer, Inc.
-
Esther Straghan has nothing to disclose.
-
Dr. Fullerton has received personal compensation for serving as an employee of Pfizer. Dr. Fullerton has stock in Pfizer.